07.06.2018 • NewsAscendDede Willams

Ascend Adding 220,000 t to PA 6.6 Chain

Ascend Adding 220,000 t to PA 6.6 Chain (c) Ascend
Ascend Adding 220,000 t to PA 6.6 Chain (c) Ascend

Houston, Texas-based polyamide 6.6 specialist Ascend Performance Materials has provided details of the planned 10-15% expansion of its value chain – acrylonitrile, adiponitrile, hexamethylene diamine, adipic acid and polymers – announced last year.

The company that regards itself as the world’s largest fully integrated producer of PA 6.6 resin said last year that global demand for its product range across diverse application was growing at 3-4% annually.

Up to 2022, Ascend will add a total of 220,000 t/y to its existing acrylonitrile (ADN) capability of around 400,000 t/y before the project began. The first expansion stage at the US company’s Decatur, Alabama, facility was completed at the end of 2017, adding 50,000 t/y of new capacity. A second 40,000 t/y expansion stage is planned to be completed by the end of 2018, with an additional 180,000 t/y scheduled to be in place by 2022.

CEO Phil McDivitt said Ascend is “committed to supporting the growth of the nylon 6,6 chain globally and has consistently increased capacity throughout the chain as demand increased.” With its latest fifth generation ADN technology, he said the company is able to add capacity without extensive down time.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.